Krishna Yeshwant - Net Worth and Insider Trading
Krishna Yeshwant Net Worth
The estimated net worth of Krishna Yeshwant is at least $75 Million dollars as of 2024-12-26. Krishna Yeshwant is the Director, 10% Owner of Verve Therapeutics Inc and owns about 12,168,489 shares of Verve Therapeutics Inc (VERV) stock worth over $74 Million. Krishna Yeshwant is also the Director of Foundation Medicine Inc and owns about 5,786 shares of Foundation Medicine Inc (FMI) stock worth over $792,682. Details can be seen in Krishna Yeshwant's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Krishna Yeshwant has not made any transactions after 2023-12-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Krishna Yeshwant
Krishna Yeshwant Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Krishna Yeshwant owns 2 companies in total, including Verve Therapeutics Inc (VERV) , and EQRx Inc (EQRX) .
Click here to see the complete history of Krishna Yeshwant’s form 4 insider trades.
Insider Ownership Summary of Krishna Yeshwant
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VERV | Verve Therapeutics Inc | 2023-12-01 | director & 10 percent owner |
| EQRX | EQRx Inc | 2021-12-17 | director |
Krishna Yeshwant Latest Holdings Summary
Krishna Yeshwant currently owns a total of 2 stocks. Among these stocks, Krishna Yeshwant owns 12,168,489 shares of Verve Therapeutics Inc (VERV) as of December 1, 2023, with a value of $74 Million and a weighting of 98.94%. Krishna Yeshwant also owns 5,786 shares of Foundation Medicine Inc (FMI) as of August 8, 2017, with a value of $792,682 and a weighting of 1.06%.
Latest Holdings of Krishna Yeshwant
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VERV | Verve Therapeutics Inc | 2023-12-01 | 12,168,489 | 6.09 | 74,106,098 |
| FMI | Foundation Medicine Inc | 2017-08-08 | 5,786 | 137.00 | 792,682 |
Holding Weightings of Krishna Yeshwant
Krishna Yeshwant Form 4 Trading Tracker
According to the SEC Form 4 filings, Krishna Yeshwant has made a total of 4 transactions in Verve Therapeutics Inc (VERV) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Verve Therapeutics Inc is the acquisition of 1,800,000 shares on December 1, 2023, which cost Krishna Yeshwant around $18 Million.
According to the SEC Form 4 filings, Krishna Yeshwant has made a total of 0 transactions in Foundation Medicine Inc (FMI) over the past 5 years. The most-recent trade in Foundation Medicine Inc is the sale of 4,800 shares on August 8, 2017, which brought Krishna Yeshwant around $192,048.
Insider Trading History of Krishna Yeshwant
- 1
Krishna Yeshwant Trading Performance
GuruFocus tracks the stock performance after each of Krishna Yeshwant's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Krishna Yeshwant is 38.17%. GuruFocus also compares Krishna Yeshwant's trading performance to market benchmark return within the same time period. The performance of stocks bought by Krishna Yeshwant within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Krishna Yeshwant's insider trading performs compared to the benchmark.
Performance of Krishna Yeshwant
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.24 | | | | | |
| Relative Return to S&P 500(%) | 14.43 | | | | | |
Krishna Yeshwant Ownership Network
Krishna Yeshwant Owned Company Details
What does Verve Therapeutics Inc do?
Who are the key executives at Verve Therapeutics Inc?
Krishna Yeshwant is the director & 10 percent owner of Verve Therapeutics Inc. Other key executives at Verve Therapeutics Inc include Chief Financial Officer Allison Dorval , See Remarks Andrew D. Ashe , and Chief Administrative Officer Joan Nickerson .
Verve Therapeutics Inc (VERV) Insider Trades Summary
Over the past 18 months, Krishna Yeshwant made 1 insider transaction in Verve Therapeutics Inc (VERV) with a net purchase of 1,800,000. Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net sale of 1,109 shares made by Allison Dorval , a net purchase of 76,000 shares made by Andrew D. Ashe , and a net sale of 1,514 shares made by Joan Nickerson .
In summary, during the past 3 months, insiders sold 555 shares of Verve Therapeutics Inc (VERV) in total and bought 0 shares, with a net sale of 555 shares. During the past 18 months, 2,623 shares of Verve Therapeutics Inc (VERV) were sold and 1,876,000 shares were bought by its insiders, resulting in a net purchase of 1,873,377 shares.
Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verve Therapeutics Inc Insider Transactions
Krishna Yeshwant Mailing Address
Above is the net worth, insider trading, and ownership report for Krishna Yeshwant. You might contact Krishna Yeshwant via mailing address: C/o Google Ventures 2011, L.p., 1600 Amphitheatre Parkway, Mountain View Ca 94043.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
